Profile picture

Doctor Masato Okada

Sakurabashi-Watanabe Hospital, Osaka (Japan)
Membership: ESC Professional Member
Follow
Biography
Dr. Masato Okada is a cardiologist at Sakurabashi Watanabe Hospital, Osaka, Japan. He graduated from Osaka University in 2008, and was trained in general cardiology and electrophysiology at Osaka Police Hospital. From 2015, he has worked at Sakurabashi Watanabe Hospital as a cardiologist and specializes in arrhythmias. His field of interest is the role of arrhythmias in the progression of heart failure.
Logo ESC

Contributor content

Associations between rapid renal function decline and prior cardiovascular events in patients with heart failure and preserved ejection fraction: insights from the PURSUIT-HFpEF registry
Presentation
Associations between rapid renal function decline and prior cardiovascular events in patients with heart failure and preserved ejection fraction: insights from the PURSUIT-HFpEF registry
Size-dependent efficacy of low-voltage area ablation in persistent atrial fibrillation: a subanalysis of the SUPPRESS-AF trial
Presentation
Size-dependent efficacy of low-voltage area ablation in persistent atrial fibrillation: a subanalysis of the SUPPRESS-AF trial
Age-predicted maximal heart rate reserve as an alternative prognostic parameter in patients with heart failure with preserved ejection fraction -insights from PURSUIT-HFpEF registry-
Presentation
Age-predicted maximal heart rate reserve as an alternative prognostic parameter in patients with heart failure with preserved ejection fraction -insights from PURSUIT-HFpEF registry-
Elucidating the mechanism of rapid functional recovery following atrial fibrillation ablation in patients with left ventricular systolic dysfunction
Presentation
Elucidating the mechanism of rapid functional recovery following atrial fibrillation ablation in patients with left ventricular systolic dysfunction
Impact of bleeding events on mortality in patients with atrial fibrillation and silent left atrial thrombi: insight from the LAT trial
Presentation
Impact of bleeding events on mortality in patients with atrial fibrillation and silent left atrial thrombi: insight from the LAT trial
Left atrioventricular coupling index as a prognostic marker of cardiovascular events in heart failure with preserved ejection fraction
Presentation
Left atrioventricular coupling index as a prognostic marker of cardiovascular events in heart failure with preserved ejection fraction
Reappraising the role of baseline plasma C-reactive protein levels on recurrence after catheter ablation of persistent atrial fibrillation: insight from EARNEST-PVI trial
Presentation
Reappraising the role of baseline plasma C-reactive protein levels on recurrence after catheter ablation of persistent atrial fibrillation: insight from EARNEST-PVI trial
Association between myocardial wall thickness and left ventricular functional recovery after catheter ablation of atrial fibrillation in patients with reduced ejection fraction
Presentation
Association between myocardial wall thickness and left ventricular functional recovery after catheter ablation of atrial fibrillation in patients with reduced ejection fraction
The impact of frailty and aging on prognosis in patients with heart failure with preserved ejection fraction - insights from PURSUIT-HFpEF registry -
Presentation
The impact of frailty and aging on prognosis in patients with heart failure with preserved ejection fraction - insights from PURSUIT-HFpEF registry -
The comparison of clinical significance between atrial and ventricular structural remodeling in patients with heart failure with preserved ejection fraction - insights from PURSUIT-HFpEF registry
Presentation
The comparison of clinical significance between atrial and ventricular structural remodeling in patients with heart failure with preserved ejection fraction - insights from PURSUIT-HFpEF registry

ESC 365 is supported by